Safety Assessment of High- and Low-Molecular-Weight Hyaluronans (Profhilo®) as Derived from Worldwide Postmarketing Data

Table 2

Sales details referring to the number of syringes sold (in EU and non-EU countries) and estimated patient exposure.

Period	No. of syringes sold worldwide	No. of patients exposed
2015-2016	46,943 (42,982 EU countries; 3,961 non-EU countries)	6,706
2016-2017	91,613 (80,162 EU countries; 11,451 non-EU countries)	13,088
2017-2018	158,201 (131,548 EU countries; 26,653 non-EU countries)	22,600